GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91024F00002UNIVERSITY OF OKLAHOMA

Overview

Award facts

Net obligations
$760.55K
$760,552of $1.89M potential value
Outlays (paid to date)
$760.55K
$760.55K paid of $760.55K obligated$760,552
Period of performance
Jun 17, 2024 to Jun 16, 2026
Ended
Modifications
4
Latest action Jun 22, 2026
Contract type
Delivery order
PIID 75N91024F00002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS

Dates and value

Award date
Signed on Jun 17, 2024
Current value
$760,552Base and exercised options
Potential value (if all options are exercised)
$1,886,812
Parent contract vehicle
75N91024D00005 (IDC, multiple award) — 3 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$4,328 (de-obligation)
  • FY2024: $764,880

Total across 2 fiscal years: $760,552

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 22, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationOKLAHOMA CITY, OK
UEIGY8NMUZQXVS7
CAGE code4B862
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Oklahoma City, Oklahoma County, Oklahoma 73104-3609
Congressional district (place of performance)
OK-05As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
TORFP 2024 E-01(as reported)
Solicitation date
Feb 13, 2024

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Prevent cancer preclinical drug development program: preclinical efficacy and intermediate endpoint
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 17, 2024Base obligation at award: $764,880
Latest action
Jun 22, 2026 — Supplemental agreement (within scope)Modification P00004; obligation change -$4,328
Latest substantive action
Jun 22, 2026 — Supplemental agreement (within scope)Modification P00004; obligation change -$4,328
Actions by type
  • Base award1
  • Supplemental agreement (within scope)4
5 actions recorded, Jun 17, 2024 to Jun 22, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$4,328
Latest action: change in base and all options
-$4,328

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Bio-basedE
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
5

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2024/2024-0849-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression